Chromosomal translocations in benign tumors: The HMGI proteins

American Journal of Clinical Pathology

Volumn 109, Issue 3, 1998, Pages 251-261

  Hess, Jay L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosomal translocations; High mobility group proteins; HMGI(Y); HMGI C; Solid tumor cytogenetics

Indexed keywords

BENIGN TUMOR; CARCINOGENESIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; FIBROADENOMA; HAMARTOMA; HUMAN; LEIOMYOMA; LIPOMA; MYXOMA; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; REVIEW;

EID: 0031936644     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.3.251     Document Type: Review

References (129)

1. Nowell FC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497. Abstract.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290-293.
3. Chaganti RSK. Cytogenetics of leukemia and lymphoma. In: Berard CW, Dorfman RF, Kaufman N, eds. Malignant Lymphoma. Baltimore, Md: Williams & Wilkins; 1987.
4. Heim S, Mitleman F. Cancer Cytogenetics. 2nd ed. New York, NY: Liss; 1995.
5. Testa JR, Oguma N, Misawa S, et al. Chromosome changes in leukemia. In: Chaganti RSK, German J, eds. Genetics in Clinical Oncology. New York, NY: Oxford University Press; 1985.
6. Rabbitts TH. Chromosomal translocations in human cancer. Nature. 1994;372:143-149.
7. Zech L, Haglund V, Nilsson K, et al. Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer. 1976;17:47-56.
8. Bernheim A, Berger R, Lenoir G. Cytogenetic studies on African Burkitt's lymphoma cell lines; t(8;14), t(2;8) and t(8;22) translocations. Cancer Genet Cytogenct. 1981;3:307-315.
9. Haluska FG, Tsujimoto Y, Croce CM. The molecular genetics of non-Hodgkin's lymphomas. In: Magrath I, ed. The Non-Hodgkin's Lymphomas. Baltimore, Md: Williams & Wilkins; 1990:96-108.
10. Rowley JD. Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. J Clin Oncol. 1988;6:919-925.
11. Ngan B, Chen-Levy Z, Weiss L, et al. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med. 1988;318:1638-1644.
12. Tsujimoto Y, Finger LR, Yunis JJ et al. Cloning of the chromosome break-point of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1098-1099.
13. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a break-point cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985;82:7439-7443.
14. Nilbert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer. 1990;2:3-13.
15. Pandis N, Heim S, Willen H, et al. Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 1991;55:11-18.
16. Sreekantaiah C, Leong SLP, Karakousis CP, et al. Cytogenetic profile of 109 lipomas. Cancer Res. 1991;51:422-433.
17. Mandahl N, Höglund M, Mertens F, et al. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer. 1994;9:207-215.
18. Birdsal SH, MacLennan KA, Gusterson BA. t(6;12)(q23;q13) and t(10;16)(q22;p11) in a phylloides tumor of the breast. Cancer Genet Cytogenet. 1992;60:74-77.
19. Rohen C, Bonk U, Staats B, et al. Two human breast tumors with translocations involving 12q13-15 as the sole cytogenetic abnormality. Cancer Genet Cytogenet. 1993;69:68-71.
20. Calabrese G, DiVirgilio C, Cianchetti E, et al. Chromosome abnormalities in breast fibroadenomas. Genes Chromosomes Cancer. 1991;3:202-204.
21. Sandros J, Stenman G, Mark J. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet. 1990;44:153-167.
22. Bullerdiek J, Wobst G, Meyer-Bolte K, et al. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet. 1993;65:27-31.
23. Walter TA, Xuan Fan S, Medchill MT, et al. Inv(12)(p11.2q13) in an endometrial polyp. Cancer Genet Cytogenet. 1989;41:99-103.
24. Vanni R, Dal Cin P, Marras S, et al. Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. Cancer Genet Cytogenet. 1993;68:32-33.
25. Mandahl N, Heim S, Arheden K, et al. Chromosomal rearrangements in chondromatous tumors. Cancer. 1989;65:242-248.
26. Bridge JA, Persons DL, Neff JR, et al. Clonal karyotypic aberrations in enchondroma. Cancer Detect Prev. 1992;16:215-219.
27. Dal Cin P, Kools P, De Jonge I, et al. Rearrangement of 12q14-15 in pulmonary chondroid hamartoma. Genes Chromosomes Cancer. 1993;8:131-133.
28. Schoenberg Fejzo M, Yoon SJ, Montgomery KT, et al. Identification of a YAC spanning the translocation break-points in uterine leiomyomata, pulmonary chondroid hamartoma and lipoma: physical mapping of the 12q14-15 breakpoint region in uterine leiomyomata. Genomics. 1995;26:265-275.
29. Fletcher CDM, Akerman M, Dal Cin P, et al. Correlation between clinicopathologic features and karyotype in lipomatous tumors: a report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol. 1996;148:623-030.
30. Schoenmakers EFPM, Geurts JMW, Kools PFJ, et al. A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Genomics. 1995;29:665-678.
31. Ashar HR, Schoenberg Fejzo M, Tkachenko A, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell. 1995;82:57-65.
32. Schoenmakers EFPM, Wanschura S, Mols R, et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C in benign mesenchymal tumors. Nat Genet. 1995;10:436-444.
33. Xiao S, Lux ML, Reeves R, et al. HMG-I(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol. 1997;150:901-910.
34. Williams AJ, Powell WL, Collins T, et al. HMGI(Y) expression in human uterine leiomyomata. Am J Pathol. 1997; 150:911-918.
35. Fletcher JA, Pinkus GS, Weidner N, et al. Lineage-restricted clonality in biphasic solid tumors. Am J Pathol. 1991;138:1199-1207.
36. Fletcher JA, Pinkus GS, Donovan K, et al. Clonal rearrangement of band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. Cancer Res. 1992;2:6224-6228.
37. Fletcher JA, Pinkus JL, Lage JM, et al. Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp. Genes Chromosomes Cancer. 1992;5:260-263.
38. Johns EW. In: Johns EW, ed. The HMG Chromosomal Proteins. New York, NY: Academic Press; 1982:1-7.
39. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta. 1990;1049:231-243.
40. Bustin M, Reeves R. High mobility group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 1996;54:35-100.
41. Grosschedl R, Giese K, Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 1994;10:94-100.
42. Bianchi ME. The HMG-box domain. In: Lilley DM, ed. DNA-Protein Structural Interactions. Oxford, England: IRL Press; 1995:177-200.
43. Bianchi ME, Falciola L, Ferrari J, et al. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 1992;11:1055-1063.
44. Weir HM, Kraulis PJ, Hill CS, et al. The structure of the HMG box motif in the B-domain of HMG1. EMBO J. 1993;12:1311-1319.
45. Goodfellow PN, Lovell-Badge R. SRY and sex determination in mammals. Annu Rev Genet. 1993;27:71-92.
46. Verbeek S, Izon D, Hofhuis F, et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature. 1995;374:70-74.
47. Giese K, Cox J, Grosschedl R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell. 1992;69:185-195.
48. Laudet V, Stehelen D, Clevers H. Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res. 1993;21:2493-2501.
49. Sugimoto A, Iino Y, Maeda T, et al. Schizosaccharomyces pombe ste 11+ encodes a transcription factor with an HMG motif that is a critical regulator of sexual development. Genes Dev. 1991;5:1990-1999.
50. Lowry CV, Cerdan ME, Zitomer RS. ROX1 encodes a heme-induced repression factor regulating ANB1 and CYC7 of Saccharomyces cerevisiae. Mol Cell Biol. 1990;10:5921-5926.
51. Paull T, Haykinson M, Johnson RC. The nonspecific DNA-binding and -bending proteins HMG-1 and HMG-2 promote the assembly of complex nucleoprotein structures. Genes Dev. 1993;7:1521-1534.
52. Pil PM, Chow CS, Lippard SJ. High-mobility-group 1 protein mediates DNA bending as determined by ring closures. Proc Natl Acad Sci U S A. 1993;90:9465-9469.
53. Ding HF, Rimsky S, Batson SC, et al. Stimulation of RNA polymerase II elongation by chromosomal protein HMG-14. Science. 1994;265:796-799.
54. Trieschmann I, Alfonso PJ, Crippa MP, et al. Incorporation of chromosomal proteins HMG-14/HMG-17 into nascent nucleosomes induces an extended chromatin configuration and enhances the activation of active transcription complexes. EMBO J. 1995;14:1478-1489.
55. Paranjape SM, Krumm A, Kadonaga JT. HMG-17 is a chromatin-specific transcriptional activator that increases the efficiency of transcription initiation. Genes Dev. 1995;9:1978-1991.
56. Manfioletti G, Giancotti V, Bandiera A, et al. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res. 1991;19:6793-6797.
57. Patel UA, Bandiera A, Manfioletti G, et al. Expression and cDNA cloning of human HMGI-C phosphoprotein. Biochem Biophys Res Commun. 1994:201;63-70.
58. Friedmann M, Holth LT, Zoghbi HY, et al. Organization, inducible-expression and chromosome localization of the human HMGI(Y) non-histone protein gene. Nucleic Acids Res. 1993;21:4259-4267.
59. Reeves R, Nissen MS. The A-T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: a novel peptide motif for recognizing DNA structure. J Biol Chem. 1990;265:8573-8582.
60. Saitoh Y, Laemmli UK. From the chromosomal loops to the classic bands of metaphase chromosomes. Cold Spring Harb Symp Quant Biol. 1993;58:755-765.
61. Saitoh Y. Laemmli UK. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell. 1994;75:609-622.
62. Gasser SM, Laemmli UK. A glimpse at chromosomal order. Trends Genet. 1987;3:16-22.
63. cdc2: in vivo veritas. Cell. 1990;61:549-551.
64. Reeves R. Langan TA, Nissen MS. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. Proc Natl Acad Sci U S A. 1991;88:1671-1675.
65. Nissen MS, Langan TA, Reeves R. Phosphocylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J Biol Chem. 1991;266:19945-19952.
66. cdc13 kinase. Eur J Biochem. 1991;196:557-567.
67. Reeves R. Chromatin changes during the cell cycle. Curr Opin Cell Biol. 1992;4:413-423.
68. Thanos D, Maniatis T. The high mobility group protein HMG-I(Y) is required for NF-κB-dependent virus induction of the human IFNβ gene. Cell. 1992;71:777-789.
69. Wolffe A. Architectural factors. Science. 1994;264:1100-1101.
70. Fashena SJ, Reeves R, Ruddle NH. A poly (dA-dT) upstream activating sequence binds high mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation. Mol Cell Biol. 1992;12:894-903.
71. Du W, Thanos D, Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell. 1993;74:887-898.
72. John S, Reeves RB, Lin J-X, et al. Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol Cell Biol. 1995;15:1786-1796.
73. Whitley MZ, Thanos D, Read MA, et al. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol. 1994;14:6464-6475.
74. Wood LD, Farmer AA, Richmond A. HMGI(Y) and Sp1 in addition to NF-κB regulate transcription of the MGSA/GROα gene. Nucleic Acids Res. 1995;23:4210-4219.
75. French SW, Schmidt MC, Glorioso JC. Involvement of a high-mobility group protein in the transcriptional activity of the herpes simplex virus latency-active promoter 2. Mol Cell Biol. 1996;16:5393-5399.
76. Chuvpilo S, Schomberg C, Gerwig R, et al. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are a part of the interleukin-4 promoter. Nucleic Acids Res. 1993;21:5694-5704.
77. Skalnick DG, Neufeld EJ. Sequence specific binding of HMG-I(Y) to the proximal promoters of the GP91-PHOX gene. Biochem Biophys Res Commun. 1992;187:563-569.
78. Kim J, Reeves R, Rothman P, et al. The non-histone chromosomal protein HMG-I(Y) contributes to the immunoglobulin heavy chain germ-line epsilon RNA promoter. Eur J Immunol. 1995;25:798-808.
79. Rogalla P, Drechsler K, Frey G, et al. HMGI-C expression patterns in human tissues: implications for the genesis of frequent mesenchymal tumors. Am J Pathol. 1996;149:775-779.
80. Zhou X, Benson KF, Ashar HR, et al. Mutation responsible for mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995:376:771-774.
81. Xiang X, Benson KF, Chada K. Mini-mouse: disruption of the pygmy locus in a transgenic insertional mutant. Science. 1990;247:967-969.
82. Johnson KR, Lehn DA, Elton TS, et al. The chromosomal high mobility group protein HMG-I (Y): complete murine cDNA sequence, and tissue expression. J Biol Chem. 1988;263:18338-18342.
83. Johnson KR, Disney JE, Wyatt CR, et al. Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation. Exp Cell Res. 1990;187:69-76.
84. Lundberg K, Karlson JR, Ingebrigtsen K, et al. On the presence of the chromosomal proteins HMG I and HMG Y in rat organs. Biochim Biophys Acta. 1989;1009:277-279.
85. Goodwin GH, Cockerill PN, Kellam S, et al. Fractionation by high-performance liquid chromatography of the low-molecular mass high-mobility-group (HMG) chromosomal proteins present in proliferating rat cells and an investigation of the HMG proteins present in virus transformed cells. Eur J Biochem. 1985;149:47-51.
86. Giancotti V, Buratti E, Perissin L, et al. Analysis of HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res. 1989;184:538-545.
87. Friedman M, Holth LT, Zoghbi HY, et al. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 1993;21:4259-4267.
88. Lund T, Skålhegg BS, Holtlund J, et al. Fractionation and identification of metaphase-specific phosphorylated forms of high-mobility-group proteins. Eur J Biochem. 1987;166:21-26.
89. Ogram SA, Reeves R. Differential regulation of a multipromoter gene. J Biol Chem. 1995;270:14235-14242.
90. Giancotti V, Pani B'nra P, Berlingieri MT, et al. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J. 1987;6:1981-1987.
91. Ram TG, Reeves R, Hosick HL. Elevated high mobility group-I(Y) expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 1993;53:2655-2660.
92. Bussemakers MJG, Van de Ven WJM, Debruyne FMJ, et al. Identification of high mobility group protein I(Y) as potential marker for prostate cancer by differential hybridization analysis. Cnncer Res. 1991;51:606-611.
93. Tamimi Y, van der Pool HG, Denyn M-M, et al. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 1993;53:5512-5516.
94. Giancotti V, Bandiera A, Buratti E, et al. Analysis of multiple forms of the HMGI proteins in rodent and human cells: identification of the third protein, HMGI-C in human cells. Eur J Biochem. 1991;198:211-216.
95. Giancotti V, Bandiera A, Ciani L, et al. High-mobility-group-proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur J Biochem. 1993;213:825-832.
96. Berlingieri MT, Manfioletti G, Santoro M, et al. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol. 1995;15:1545-1553.
97. Sadler I, Crawford AW, Michelson JW, et al. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J Cell Biol. 1992;119:1573-1587.
98. Way JC, Chalfie M. mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C elegans. Cell. 1988;54:5-16.
99. Freyd G, Kim SK, Horvitz HR. Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11. Nature. 1990;344:876-879.
100. Cohen B, McGuffin ME, Pfeifle C, et al. apterous, a gene required for imaginai disc development in Drosophila encodes a member of the LIM family of developmental regulatory proteins. Genes Dev. 1992;6:715-729.
101. German MS, Wang J, Chadwick RB, et al. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev. 1992;6:2165-2176.
102. Sánchez-Garcia I, Rabbitts TH. LIM domain proteins in leukemia and development. Semin Cancer Biol. 1993;4:349-358.
103. Valge-Archer VE, Osada H, Warren AJ, et al. The LIM protein RBTN2 and the basic helix-loop helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A. 1994;91:8617-8621.
104. Wancshura S, Dal Cin P, Kamierczak B, et al. Hidden paracentric inversions of chromosome 12q affecting the HMGIC gene. Genes Chromosomes Cancer. 1997;18:322-323.
105. Seipel K, Georgiev O, Schaffner W. Different activation domains stimulate transcription from remote ("enhancer") and proximal ("promoter") positions. EMBO J. 1992;11:4961-4968.
106. Mitchell PJ, Tijan R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989;245:371-378.
107. Schoenberg Fejzo M, Ashar HR, Krauter KS, et al. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer. 1996;17:1-6.
108. Kazmierczak B, Hennig Y, Wanschura S, et al. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res. 1995;55:6038-6039.
109. Kools PF, Van de Ven Wim JM. Amplification of a rearranged form of the high mobility group protein gene HMGIC in OSA-CI osteosarcoma cells. Cancer Genet Cytogenet. 1996;91:1-7.
110. Fletcher JA, Pinkus GS, Donovan K, et al. Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. Cancer Res. 1992;52:6224-6228.
111. Nilbert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromsomes Cancer. 1990;2:3-13.
112. Fletcher JA, Longtine J, Wallace K, et al. Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: evidence for a pathogenetic relationship with lipomas and leiomyomas. Genes Chromosomes Cancer. 1995;12:220-223.
113. Johansson M, Dietrich C, Mandahl N, et al. Recombinations of chromosomal bands 6p21 and 14q24 characterize pulmonary hamartomas. Br J Cancer. 1993;67:1236-1241.
114. Ancsin JB, Kisilevsky R. Laminin interactions important for basement membrane assembly are promoted by zinc and implicate laminin zinc finger-like sequences. J Biol Chem. 1996;271:6845-6851.
115. Gu Y, Nakamura T, Alder R, et al. The t(4;11) translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. 1992;71:701-708.
116. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 1992:71:691-700.
117. Djabali M, Selleri L, Parry P, et al. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukemias. Nat Genet. 1992;2:113-118.
118. Domer PH, Fakharzadeh SS, Chen C-S, et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci U S A. 1993;90:7884-7888.
119. Rubnitz JE, Behm FG, Downing JR. 11q23 rearrangements in acute leukemia. Leukemia. 1996;10:74-82.
120. Zeleznik-Le NJ, Harden AM, Rowley JD. 11q23 translocations split the 'AT-hook' cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed lineage leukemia (MLL) gene. Proc Natl Acad Sci U S A. 1994;91:10610-10614.
121. Broeker PL, Harden A, Rowley JD, et al. The mixed lineage leukemia gene (MLL) protein involved in 11q23 translocations contains a domain that binds cruciform DNA and scaffold attachment region (SAR) DNA. Curr Top Microbiol Immunol. 1996;211:259-268.
122. Adler H, Tkachuk D. Leukemic HRX fusion proteins contain novel protein-protein/DNA interaction domains that bind another leukemic factor, the SET protein. Blood. 1996;88(suppl 1):549a. Abstract.
123. Caslini C, Murti KG, Ashmun RA, et al. Subcellular localization of the MLL-AF4 fusion oncoprotein. Blood. 1996;88(suppl 1):557a. Abstract.
124. Farnet CM, Bushman FD. HIV cDNA integration: requirement of HMG-I(Y) protein for function of preintegration complexes in vitro. Cell. 1997;88:483-492.
125. Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science. 1965;150:67-69.
126. Townsend DE, Sparkes RS, Balvda MC, et al. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 1970;107:1168-1173.
127. Mashal RD, Schoenberg Fejzo ML, Friedman AJ, et al. Analysis of androgen receptor DNA reveals the independent clonal origin of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer. 1994;11:1-6.
128. Kas K, Voz ML, Röijer E, et al. Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet. 1997;15:170-174.
129. Fletcher JA. Cytogenetic analysis of soft tissue tumors. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. 3rd ed. St Louis, Mo: Mosby; 1995.